10/24/2007

Mylan Laboratories and GlaxoSmithKline have agreed to settle a patent dispute over the antidepressant Paxil CR. The agreement allows Mylan to launch generic versions of Paxil CR beginning no later than Oct. 1, 2008.

Related Summaries